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The pioneering work of Grobstein, Saxen and Sariola, led to the development of culture systems 
that could support the growth and differentiation of mouse kidney rudiments in vitro.
1
 Cultured 
kidney rudiments can be easily manipulated, either genetically or by the application of growth 
factors, inhibitors, or other small biological substances, and are thus useful model systems for 
investigating the mechanisms that regulate the development of the mammalian kidney. Kidney 
rudiments have also been evaluated for their potential to integrate into mature kidneys and treat 
renal insufficiency. Woolf et al. showed that rudiments transplanted into neonatal mouse kidneys 
generated functional nephrons with filtering capacity,
2
 with subsequent studies by Rogers and 
Hammerman demonstrating that transplanted rudiments could improve survival in anephric rats, 
albeit for only a few days.
3
 However, despite these promising results, further studies by Ashton 
and co-workers showed that while the kidney rudiments continued to develop for a few weeks 
following transplantation, by three months, their level of maturity only reached that of early 
neonatal kidneys.
4
  This meant that the glomerular filtration rate (GFR) of the transplanted 
rudiments was equivalent to only 2% of the GFR of an adult rat kidney, which explains why the 
rudiments were unable to sustain life in anephric rodents beyond a few days. 
 
Although these studies suggest that kidney rudiments are unlikely to have much therapeutic value 
when transplanted into diseased kidneys, they can nevertheless be very effective tools for 
assessing the nephrogenic potential of various types of stem and progenitor cells. For instance, 
following on from the work of Atala and co-workers,
5
 who found that disaggregated metanephroi 
isolated from bovine embryos could self-organise to form functioning nephrons, Unbekandt and 
Davies developed an assay that involved disaggregating mouse kidney rudiments to single cells, 
combining them with exogenous stem/progenitor cells, and then allowing the cells to re-aggregate 
to form chimeric kidney rudiments.
6 
 These chimeric rudiments could be cultured in vitro, 
presenting excellent test systems for assessing whether the exogenous stem cells are capable of 
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generating specialized renal cells.
6
 Using this assay, it has been shown that certain types of stem 
cells, most notably, pluripotent stem cells
7
 and amniotic fluid stem cells (AFSCs),
8
 are capable of 
integrating into developing renal structures and generating specialized renal cells, whereas other 
cell types, such as mesenchymal stem/stromal cells (MSCs) are unable to do so,
9
 unless they have 
been engineered to over-express glial cell line-derived neurotrophic factor (GDNF).
10
   
 
The chimeric kidney rudiment assay therefore allows researchers to identify stem cell types with 
nephrogenic potential that could potentially be used for applications in regenerative medicine, 
drug discovery and disease modelling. However, although the chimeric rudiment assay is very 
useful for investigating whether different stem cell types can participate in nephron development, 
and can even be used with great effect to test the functionality of stem cell-derived proximal 
tubule cells,
7
 a major drawback with the in vitro kidney rudiment system is that endothelial cells 
do not invest the developing glomeruli, and consequently, there is an absence of capillary loops, 
resulting in the failure of podocyte maturation. Furthermore, the lack of vasculature means that 
the podocytes are unable to perform selective filtration as they would in vivo, and hence, the 
functionality of stem cell-derived podocytes cannot be tested.  However, a study by Xinaris et al.
11
 
has shown that if re-aggregated rudiments, also referred to as kidney ‘organoids’, are transplanted 
into adult rat kidneys, they can generate vascularised glomeruli with capillary loops and slit 
diaphragms that appear to have some filtration capacity. 
 
In this issue of JASN, Xinaris et al.
12
 have extended these studies to (i) explore whether re-
aggregated mouse rudiments can perform ultrafiltration; (ii) assess the nephrogenic potential of 
hAFSCs within chimeric rudiments comprised of re-aggregated mouse metanephroi; (iii) determine 
whether the hAFSCs within the chimeras can generate mature, functional podocytes following 
transplantation into mature rat kidneys.  Using electron microscopy, the authors first show that 
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following transplantation into the kidneys of uni-nephrectomised athymic adult rats, re-
aggregated mouse kidney rudiments could generate vascularized glomeruli, some of which 
contained mature podocytes with well-developed foot processes and slit diaphragms. The 
functionality of the glomeruli was then investigated using fluorescently labelled dextrans of low 
(10 kDa, 70 kDa) and high (155 kDa) molecular weight. Some of the nephrons that formed within 
the chimeric rudiments were found to be capable of performing ultrafiltration, as evidenced by 
their ability to filter the low molecular weight dextrans, but exclude the high molecular weight 
dextran. The authors then evaluated the nephrogenic potential of the hAFSCs. In contrast to a 
previous study,
8
 the authors showed that hAFSCs within chimeric rudiments cultured in vitro had a 
limited capacity to integrate into developing renal structures, but if genetically modified with an 
adenovirus vector encoding GDNF, they could become incorporated into the condensed 
metanephric mesenchyme. When chimeric rudiments containing GDNF-expressing hAFSCs were 
cultured for 1 day in vitro and then transplanted into mature rat kidneys, immunofluorescence 
analysis showed that the hAFSCs could readily form podocytes. The ability of the hAFSCs to form 
mature podocytes was confirmed using immuno-electron microscopy, which showed that the 
hAFSC-derived podocytes had well-developed foot processes and slit diaphragms. Finally, to 
demonstrate functionality, dual immunogold staining for a human-specific antigen and bovine 
serum albumin was performed to show that hAFSC-derived podocytes were able to endocytose 
albumin. An interesting finding of the Xinaris et al. study is that the hAFSCs had a marked 
propensity to form podocytes, and rarely formed proximal tubule cells. The reasons for this are 
not entirely clear, but the authors obtained the same result using two different hAFSC lines, 
indicating that the tendency of the hAFSCs to form podocytes was not a peculiarity of any one 
particular hAFSC line. 
 
An important aspect of the Xinaris et al. study
12
 is that it shows how transplanted chimeric 
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rudiments could potentially be used to model diseases affecting human podocytes. For instance, 
the use of hAFSCs with mutations in genes that affect podocyte differentiation, growth, survival 
and/or function, would allow detailed studies of the processes of disease initiation and 
progression, and the evaluation of possible therapies. Furthermore, by using patient-derived 
human induced pluripotent stem cells (hiPSCs) instead of hAFSCs, it would be possible to 
investigate a wider range of human kidney diseases, due to the fact that unlike hAFSCs, iPSCs 
cultured under the appropriate conditions can generate the full suite of cell types that comprise 
the nephron.
13
  
 
Could chimeric kidney organoids be used to treat renal insufficiency? At present, this seems 
unlikely, because in addition to the aforementioned issues with low GFR that have been reported 
following the transplantation of intact rudiments,
4
 in the re-aggregated chimeric rudiments, there 
is the additional problem of the ureteric bud tree not being continuous, making it unable to 
transfer urine from the cortico-medullary region to the renal pelvis. 
 
In conclusion, Xinaris et al.
12
 report that if hAFSCs are engineered to express GDNF and are then 
combined with disaggregated mouse kidney rudiments to form chimeric kidney organoids, the 
hAFSCs can differentiate to form functional podocytes following transplantation into adult rat 
kidneys. The authors’ technology could potentially be used as a model for understanding diseases 
affecting the podocytes, and as a system for testing novel therapies to treat podocyte disease. 
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